1	Retinal	Retinal	B-NP	JJ	O	2	NMOD	-1
2	microangiopathies	microangiopathy	I-NP	NNS	O	0	ROOT	-1
3	overlying	overlie	B-VP	VBG	O	2	NMOD	-1
4	pigment	pigment	B-NP	NN	O	6	NMOD	-1
5	epithelial	epithelial	I-NP	JJ	O	6	NMOD	-1
6	detachment	detachment	I-NP	NN	O	3	OBJ	6	detachment
7	in	in	B-PP	IN	O	3	VMOD	-1
8	age-related	age-related	B-NP	JJ	O	10	NMOD	-1
9	macular	macular	I-NP	JJ	O	10	NMOD	-1
10	degeneration	degeneration	I-NP	NN	O	7	PMOD	6	degeneration
11	.	.	O	.	O	2	P	-1

1	PURPOSE	PURPOSE	B-NP	NN	O	0	ROOT	-1
2	:	:	O	:	O	1	P	-1
3	To	To	B-VP	TO	O	4	VMOD	-1
4	evaluate	evaluate	I-VP	VB	O	1	NMOD	-1
5	alterations	alteration	B-NP	NNS	O	4	OBJ	7	alterations
6	in	in	B-PP	IN	O	5	NMOD	-1
7	the	the	B-NP	DT	O	9	NMOD	-1
8	retinal	retinal	I-NP	JJ	O	9	NMOD	-1
9	vasculature	vasculature	I-NP	NN	O	6	PMOD	-1
10	overlying	overlie	B-VP	VBG	O	9	NMOD	-1
11	pigment	pigment	B-NP	NN	O	13	NMOD	-1
12	epithelial	epithelial	I-NP	JJ	O	13	NMOD	-1
13	detachments	detachment	I-NP	NNS	O	10	OBJ	6	detachments
14	(	(	O	(	O	16	DEP	-1
15	PED	PED	B-VP	VBN	O	16	DEP	-1
16	)	)	O	)	O	13	NMOD	-1
17	in	in	B-PP	IN	O	10	VMOD	-1
18	exudative	exudative	B-NP	JJ	O	21	NMOD	-1
19	age-related	age-related	I-NP	JJ	O	21	NMOD	-1
20	macular	macular	I-NP	JJ	O	21	NMOD	-1
21	degeneration	degeneration	I-NP	NN	O	17	PMOD	6	degeneration
22	(	(	O	(	O	24	DEP	-1
23	ARMD	ARMD	B-NP	NN	O	24	DEP	-1
24	)	)	O	)	O	21	NMOD	-1
25	using	use	B-VP	VBG	O	4	VMOD	-1
26	indocyanine	indocyanine	B-NP	NN	O	27	NMOD	-1
27	green	green	I-NP	NN	O	30	NMOD	-1
28	and	and	O	CC	O	30	NMOD	-1
29	fluorescein	fluorescein	B-NP	NN	O	30	NMOD	-1
30	angiography	angiography	I-NP	NN	O	25	OBJ	0
31	.	.	O	.	O	4	P	-1

1	METHODS	METHODS	B-NP	NNS	O	0	ROOT	-1
2	:	:	O	:	O	1	P	-1
3	Forty-one	Forty-one	B-NP	CD	O	4	NMOD	-1
4	patients	patient	I-NP	NNS	O	18	SUB	-1
5	(	(	O	(	O	8	DEP	-1
6	41	41	B-NP	CD	O	7	NMOD	-1
7	eyes	eye	I-NP	NNS	O	8	DEP	-1
8	)	)	O	)	O	4	NMOD	-1
9	with	with	B-PP	IN	O	4	NMOD	-1
10	a	a	B-NP	DT	O	12	NMOD	-1
11	clinical	clinical	I-NP	JJ	O	12	NMOD	-1
12	diagnosis	diagnosis	I-NP	NN	O	9	PMOD	-1
13	of	of	B-PP	IN	O	12	NMOD	-1
14	exudative	exudative	B-NP	JJ	O	15	NMOD	-1
15	ARMD	ARMD	I-NP	NN	O	13	PMOD	-1
16	with	with	B-PP	IN	O	12	NMOD	-1
17	PED	PED	B-NP	NN	B-protein	16	PMOD	-1
18	underwent	undergo	B-VP	VBD	I-protein	1	NMOD	0
19	simultaneous	simultaneous	B-NP	JJ	I-protein	20	NMOD	-1
20	fluorescein	fluorescein	I-NP	NN	I-protein	24	NMOD	-1
21	and	and	O	CC	O	24	NMOD	-1
22	indocyanine	indocyanine	B-NP	NN	O	24	NMOD	-1
23	green	green	I-NP	JJ	O	24	NMOD	-1
24	angiography	angiography	I-NP	NN	O	18	OBJ	19	angiography
25	,	,	O	,	O	18	P	-1
26	also	also	B-ADVP	RB	O	18	VMOD	-1
27	under	under	B-PP	IN	O	18	VMOD	-1
28	high	high	B-ADJP	JJ	O	33	NMOD	-1
29	(	(	O	(	O	32	DEP	-1
30	10	10	B-NP	CD	O	31	NMOD	-1
31	degrees	degree	I-NP	NNS	O	32	DEP	-1
32	)	)	O	)	O	28	AMOD	-1
33	magnification	magnification	B-NP	NN	O	27	PMOD	-1
34	.	.	O	.	O	1	P	-1

1	Vascular	Vascular	B-NP	JJ	O	2	NMOD	-1
2	abnormalities	abnormality	I-NP	NNS	O	6	SUB	-1
3	in	in	B-PP	IN	O	2	NMOD	-1
4	the	the	B-NP	DT	O	5	NMOD	-1
5	retina	retina	I-NP	NN	O	3	PMOD	-1
6	were	be	B-VP	VBD	O	0	ROOT	-1
7	compared	compare	I-VP	VBN	O	6	VC	-1
8	between	between	B-PP	IN	O	7	VMOD	-1
9	patients	patient	B-NP	NNS	O	8	PMOD	-1
10	with	with	B-PP	IN	O	9	NMOD	-1
11	vascularized	vascularize	O	VBN	O	10	PMOD	0
12	(	(	O	(	O	19	DEP	-1
13	n	n	B-NP	NN	O	19	DEP	-1
14	=	=	B-VP	SYM	O	13	NMOD	-1
15	34	34	B-NP	CD	O	14	AMOD	-1
16	,	,	O	,	O	19	P	-1
17	group	group	B-NP	NN	O	19	DEP	-1
18	1	1	I-NP	CD	O	17	NMOD	-1
19	)	)	O	)	O	11	AMOD	-1
20	and	and	O	CC	O	36	VMOD	-1
21	nonvascularized	nonvascularized	B-NP	JJ	O	36	SUB	-1
22	(	(	O	(	O	29	DEP	-1
23	n	n	B-NP	NN	O	27	NMOD	-1
24	=	=	B-VP	SYM	O	23	NMOD	-1
25	7	7	B-NP	CD	O	24	AMOD	-1
26	,	,	O	,	O	27	P	-1
27	group	group	B-NP	NN	O	29	DEP	-1
28	2	2	I-NP	CD	O	27	NMOD	-1
29	)	)	O	)	O	21	NMOD	-1
30	PED	PED	B-VP	VBN	O	21	NMOD	-1
31	on	on	B-PP	IN	O	30	VMOD	-1
32	indocyanine	indocyanine	B-NP	NN	O	34	NMOD	-1
33	green	green	I-NP	JJ	O	34	NMOD	-1
34	angiography	angiography	I-NP	NN	O	31	PMOD	0
35	and	and	O	CC	O	36	VMOD	-1
36	correlated	correlate	B-VP	VBD	O	11	VMOD	-1
37	with	with	B-PP	IN	O	36	VMOD	-1
38	the	the	B-NP	DT	O	39	NMOD	-1
39	size	size	I-NP	NN	O	45	NMOD	-1
40	of	of	B-PP	IN	O	39	NMOD	-1
41	the	the	B-NP	DT	O	42	NMOD	-1
42	PED	PED	I-NP	NN	O	40	PMOD	-1
43	and	and	O	CC	O	45	NMOD	-1
44	the	the	B-NP	DT	O	45	NMOD	-1
45	presence	presence	I-NP	NN	O	37	PMOD	0
46	of	of	B-PP	IN	O	45	NMOD	-1
47	serous	serous	B-NP	JJ	O	49	NMOD	-1
48	retinal	retinal	I-NP	JJ	O	49	NMOD	-1
49	detachment	detachment	I-NP	NN	O	46	PMOD	6	detachment
50	.	.	O	.	O	6	P	-1

1	RESULTS	RESULTS	B-NP	NNS	O	24	VMOD	0
2	:	:	O	:	O	1	P	-1
3	In	In	B-PP	IN	O	9	VMOD	-1
4	all	all	B-NP	DT	O	8	NMOD	-1
5	,	,	O	,	O	8	P	-1
6	67	67	B-NP	CD	O	8	NMOD	-1
7	vascular	vascular	I-NP	JJ	O	8	NMOD	-1
8	abnormalities	abnormality	I-NP	NNS	O	3	PMOD	-1
9	were	be	B-VP	VBD	O	24	VMOD	-1
10	found	find	I-VP	VBN	O	9	VC	0
11	by	by	B-PP	IN	O	10	VMOD	-1
12	indocyanine	indocyanine	B-NP	NN	O	14	NMOD	-1
13	green	green	I-NP	JJ	O	14	NMOD	-1
14	angiography	angiography	I-NP	NN	O	11	PMOD	0
15	and	and	O	CC	O	10	VMOD	-1
16	only	only	B-NP	RB	O	10	VMOD	-1
17	22	22	I-NP	CD	O	16	AMOD	-1
18	by	by	B-PP	IN	O	16	NMOD	-1
19	fluorescein	fluorescein	B-NP	NN	O	20	NMOD	-1
20	angiography	angiography	I-NP	NN	O	18	PMOD	0
21	;	;	O	:	O	24	P	-1
22	this	this	B-NP	DT	O	23	NMOD	-1
23	finding	finding	I-NP	NN	O	24	SUB	-1
24	was	be	B-VP	VBD	O	0	ROOT	-1
25	statistically	statistically	B-ADJP	RB	O	24	VMOD	-1
26	significant	significant	I-ADJP	JJ	O	24	PRD	-1
27	(	(	O	(	O	32	DEP	-1
28	P	P	B-NP	NN	O	32	DEP	-1
29	less	less	B-ADJP	JJR	O	28	NMOD	-1
30	than	than	B-PP	IN	O	29	AMOD	-1
31	0.0001	0.0001	B-NP	CD	O	30	PMOD	-1
32	)	)	O	)	O	24	VMOD	-1
33	.	.	O	.	O	24	P	-1

1	The	The	B-NP	DT	O	2	NMOD	-1
2	finding	finding	I-NP	NN	O	19	SUB	-1
3	of	of	B-PP	IN	O	2	NMOD	-1
4	retinal	retinal	B-NP	JJ	O	5	NMOD	-1
5	vasculopathy	vasculopathy	I-NP	NN	O	3	PMOD	-1
6	(	(	O	(	O	18	DEP	-1
7	32	32	B-NP	CD	O	8	NMOD	-1
8	patients	patient	I-NP	NNS	O	14	NMOD	-1
9	in	in	B-PP	IN	O	8	NMOD	-1
10	group	group	B-NP	NN	O	9	PMOD	-1
11	1	1	I-NP	CD	O	10	NMOD	-1
12	and	and	I-NP	CC	O	14	NMOD	-1
13	two	two	I-NP	CD	O	14	NMOD	-1
14	patients	patient	I-NP	NNS	O	18	DEP	-1
15	in	in	B-PP	IN	O	14	NMOD	-1
16	group	group	B-NP	NN	O	15	PMOD	-1
17	2	2	I-NP	CD	O	16	NMOD	-1
18	)	)	O	)	O	5	NMOD	-1
19	was	be	B-VP	VBD	O	0	ROOT	-1
20	directly	directly	I-VP	RB	O	19	VMOD	-1
21	correlated	correlate	I-VP	VBN	O	19	VC	-1
22	with	with	B-PP	IN	O	21	VMOD	-1
23	the	the	B-NP	DT	O	24	NMOD	-1
24	presence	presence	I-NP	NN	O	22	PMOD	0
25	of	of	B-PP	IN	O	24	NMOD	-1
26	choroidal	choroidal	B-NP	JJ	O	27	NMOD	-1
27	neovascularizations	neovascularization	I-NP	NNS	O	25	PMOD	3	neovascularizations
28	(	(	O	(	O	32	DEP	-1
29	P	P	B-NP	NN	O	31	SUB	-1
30	=	=	B-VP	SYM	O	31	VMOD	-1
31	0.002	0.002	B-NP	CD	O	32	DEP	-1
32	)	)	O	)	O	21	VMOD	-1
33	.	.	O	.	O	19	P	-1

1	There	There	B-NP	EX	O	2	SUB	-1
2	was	be	B-VP	VBD	O	0	ROOT	-1
3	also	also	B-ADVP	RB	O	2	VMOD	-1
4	a	a	B-NP	DT	O	6	NMOD	-1
5	direct	direct	I-NP	JJ	O	6	NMOD	-1
6	correlation	correlation	I-NP	NN	O	2	PRD	-1
7	between	between	B-PP	IN	O	6	NMOD	-1
8	the	the	B-NP	DT	O	9	NMOD	-1
9	presence	presence	I-NP	NN	O	14	NMOD	0
10	of	of	B-PP	IN	O	9	NMOD	-1
11	choroidal	choroidal	B-NP	JJ	O	12	NMOD	-1
12	neovascularization	neovascularization	I-NP	NN	O	10	PMOD	3	neovascularization
13	and	and	I-NP	CC	O	14	NMOD	-1
14	size	size	I-NP	NN	O	7	PMOD	-1
15	of	of	B-PP	IN	O	14	NMOD	-1
16	the	the	B-NP	DT	O	17	NMOD	-1
17	PED	PED	I-NP	NN	O	15	PMOD	-1
18	(	(	O	(	O	22	DEP	-1
19	P	P	B-NP	NN	O	22	DEP	-1
20	=	=	B-VP	SYM	O	19	NMOD	-1
21	0.03	0.03	B-NP	CD	O	20	AMOD	-1
22	)	)	O	)	O	6	NMOD	-1
23	.	.	O	.	O	2	P	-1

1	The	The	B-NP	DT	O	2	NMOD	-1
2	number	number	I-NP	NN	O	7	SUB	-1
3	of	of	B-PP	IN	O	2	NMOD	-1
4	retinal	retinal	B-NP	JJ	O	6	NMOD	-1
5	vascular	vascular	I-NP	JJ	O	6	NMOD	-1
6	findings	finding	I-NP	NNS	O	3	PMOD	-1
7	was	be	B-VP	VBD	O	0	ROOT	-1
8	not	not	I-VP	RB	O	7	VMOD	-1
9	significantly	significantly	I-VP	RB	O	10	VMOD	-1
10	correlated	correlate	I-VP	VBN	O	7	VC	-1
11	with	with	B-PP	IN	O	10	VMOD	-1
12	serous	serous	B-NP	JJ	O	13	NMOD	-1
13	elevation	elevation	I-NP	NN	O	11	PMOD	17	elevation
14	of	of	B-PP	IN	O	13	NMOD	-1
15	the	the	B-NP	DT	O	16	NMOD	-1
16	retina	retina	I-NP	NN	O	14	PMOD	-1
17	.	.	O	.	O	7	P	-1

1	CONCLUSIONS	CONCLUSIONS	B-NP	NNS	O	4	NMOD	-1
2	:	:	O	:	O	1	P	-1
3	Retinal	Retinal	B-NP	JJ	O	4	NMOD	-1
4	vasculopathies	vasculopathy	I-NP	NNS	O	5	SUB	-1
5	may	may	B-VP	MD	O	0	ROOT	-1
6	be	be	I-VP	VB	O	5	VC	-1
7	observed	observe	I-VP	VBN	O	6	VC	0
8	in	in	B-PP	IN	O	7	VMOD	-1
9	eyes	eye	B-NP	NNS	O	8	PMOD	-1
10	with	with	B-PP	IN	O	9	NMOD	-1
11	PED	PED	B-NP	NN	O	10	PMOD	-1
12	and	and	O	CC	O	5	VMOD	-1
13	are	be	B-VP	VBP	O	5	VMOD	-1
14	detectable	detectable	B-ADJP	JJ	O	13	PRD	0
15	by	by	B-PP	IN	O	14	AMOD	-1
16	indocyanine	indocyanine	B-NP	NN	O	17	NMOD	-1
17	green	green	I-NP	NN	O	20	NMOD	-1
18	and	and	O	CC	O	20	NMOD	-1
19	fluorescein	fluorescein	B-NP	NN	O	20	NMOD	-1
20	angiography	angiography	I-NP	NN	O	15	PMOD	19	angiography
21	.	.	O	.	O	5	P	-1

